Dolby Laboratories (DLB) Tops Q2 EPS by 8c; Offers Strong Q3 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts DLB Hot Sheet
Price: $65.02 +2.68%
EPS Growth %: +20.2%
Financial Fact:
Research and development: 59.21M
Today's EPS Names:
COHR, ATS, SICP, More
EPS Growth %: +20.2%
Financial Fact:
Research and development: 59.21M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Dolby Laboratories (NYSE: DLB) reported Q2 EPS of $0.72, $0.08 better than the analyst estimate of $0.64. Revenue for the quarter came in at $271.9 million versus the consensus estimate of $265.46 million.
Dolby Laboratories sees Q3 2015 EPS of $0.43-$0.49, versus the consensus of $0.32. Dolby Laboratories sees Q3 2015 revenue of $230-240 million, versus the consensus of $237.1 million.
For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Envista Holdings Corp. (NVST) Tops Q3 EPS by 4c, Beats on Revenue; Offers FY26 Guidance
- Tutor Perini (TPC) Tops Q3 EPS by 92c; Offers Guidance
- Figma (FIG) Tops Q3 EPS by 5c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
